ApicHope(SZ:300723) Cai Jing Wang·2025-11-12 03:54Core Viewpoint - Recently, Yipin Hong announced that Huiyou International Limited has filed a lawsuit against Yipin Hong Pharmaceutical Co., Ltd. and related parties over a patent dispute, claiming ownership of a specific patent and seeking compensation of 528 million yuan and reasonable legal fees of 600,000 yuan [1][2]. Summary by Sections Legal Action - Huiyou International has initiated legal proceedings against Yipin Hong Pharmaceutical, Yipin Hong Pharmaceutical Group, and several associated companies and individuals, including Chairman Li Huanxiong [1]. - The lawsuit has not yet been heard in court as of the announcement date [1]. Patent and Financial Claims - The plaintiff, Huiyou International, is seeking to confirm ownership of a patent and is claiming a total of 528 million yuan in damages, which is six times the original estimated value of the patent at 88 million yuan [2]. - The lawsuit also includes a request for 600,000 yuan in reasonable legal fees [1][2]. Background of the Cooperation Agreement - In October 2014, Yipin Hong Pharmaceutical and Huiyou International signed a cooperation agreement to establish a joint venture, Guangzhou Pinrui Pharmaceutical Technology Co., Ltd., with Yipin Hong holding 52% and Huiyou International holding 48% of the shares [1]. - The agreement stipulated that Huiyou International would transfer all relevant patents and trade secrets related to the injectable prostaglandin lipid microspheres to the joint venture, which would then provide these to Yipin Hong for use [2]. - Yipin Hong has already paid 15 million yuan to Huiyou International as part of the agreement and is required to pay an additional 30 million yuan upon obtaining production approval for the lipid microspheres [2].